EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Clinical Value of MLPA for Prognostic Assessment of Chromosomal Rearrangements and DNA Methylation in Uveal Melanoma

Andrea Soltysova, Dana Dvorska, Andrej Ficek, Martina Pecimonova, Marek Samec, Ivana Kasubova, Viera Horvathova Kajabova, Lucia Demkova, Pavel Babal, Jela Valaskova, Zuzana Dankova, Bozena Smolkova and 1 more

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.3.51 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Andrea Soltysova and 12 co-authors. Institution: Department of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia. Major MEDLINE topics: DNA Methylation, Uveal Neoplasms, Melanoma, Multiplex Polymerase Chain Reaction. Cited 1 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Uveal melanoma (UM) is the most prevalent primary intraocular malignancy in adults, with prognosis significantly influenced by genetic and epigenetic factors. Reliable and cost-effective methods to detect chromosomal aberrations and DNA methylation changes are essential for improving prognostication and informing treatment strategies in UM. This study evaluated the effectiveness of multiplex ligation-dependent probe amplification (MLPA) in detecting UM-specific copy number variations (CNVs) and promoter methylation changes across 25 tumor suppressor genes (TSGs).

Methods

DNA from 58 UM tissues was analyzed with the SALSA MLPA Probemix P027 Uveal melanoma kit, and a subset of 18 samples was further assessed using the SALSA MLPA Probemix ME002-C1 Tumour suppressor mix 2 kit to identify key CNVs and methylation alterations linked to poor prognosis. Validation was carried out with a high-resolution comparative genomic hybridization (CGH) array on 10 samples and the Illumina Infinium Methylation EPIC v1.0 BeadChip array on 25 samples.

Results

Our findings indicate that MLPA is a versatile and robust method for detecting CNVs, showing strong correlations with CGH data and highlighting specific CNV patterns linked to clinical outcomes in UM. However, the ME002-C1 kit showed limited utility for comprehensive methylation analysis, as differential methylation was not observed in the studied TSG loci.

Conclusions

Although MLPA effectively identifies CNVs relevant to UM prognosis, integrating additional methylation-specific approaches could broaden the scope of DNA methylation analysis, offering a more comprehensive molecular understanding of UM that may enhance prognostication and personalized treatment.

Subjects

MeSH terms (MEDLINE)

DNA MethylationUveal NeoplasmsMelanomaMultiplex Polymerase Chain ReactionChromosome AberrationsDNA, NeoplasmHumansUveal MelanomaPrognosisDNA Copy Number VariationsMaleFemaleMiddle AgedAgedComparative Genomic HybridizationAdultAged, 80 and overPromoter Regions, Genetic

Substances

DNA, Neoplasm

Authors and institutions

  • Department of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.
  • Institute for Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
  • Department of Medical Biology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
  • Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia.
  • Institute of Pathological Anatomy, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia.

Cite

APA

Soltysova, A., Dvorska, D., Ficek, A., Pecimonova, M., Samec, M., Kasubova, I., Horvathova Kajabova, V., Demkova, L., Babal, P., Valaskova, J., Dankova, Z., Smolkova, B., & Furdova, A. (2025). Clinical Value of MLPA for Prognostic Assessment of Chromosomal Rearrangements and DNA Methylation in Uveal Melanoma. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.3.51

Vancouver

Soltysova A, Dvorska D, Ficek A, Pecimonova M, Samec M, Kasubova I, et al. Clinical Value of MLPA for Prognostic Assessment of Chromosomal Rearrangements and DNA Methylation in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.3.51

BibTeX
@article{Soltysova2025,
  author = {Soltysova, Andrea and Dvorska, Dana and Ficek, Andrej and Pecimonova, Martina and Samec, Marek and Kasubova, Ivana and Horvathova Kajabova, Viera and Demkova, Lucia and Babal, Pavel and Valaskova, Jela and Dankova, Zuzana and Smolkova, Bozena and Furdova, Alena},
  title = {Clinical Value of MLPA for Prognostic Assessment of Chromosomal Rearrangements and DNA Methylation in Uveal Melanoma},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.3.51}
}
Start for free →